The Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector

Questions? Call 888-624-8373

PAPERBACK
list:$37.00
Web:$33.30
add to cart

PDF BOOK
your price: $28.50
add to cart

Rights & Permissions

Free Resources

Related Titles

The Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector (1995)
Institute of Medicine (IOM)

Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Page
27


E-mail Facebook Digg Stumble Twitter More

Click to move to next page (28)

Page
27

Front Matter (R1-R20)

Executive Summary (1-25)

1 Introduction (26-42)

2 Overview of the State of Scientific Knowledge Concerning Drug Addiction (43-73)

3 Assessment of the Medications Development Division (74-94)

4 Treatment Setting and Effectiveness (95-119)

5 Treatment Financing and Trends in Health Insurance (120-133)

6 Training and Education (134-153)

7 Federal Laws and Regulations (154-172)

8 State Laws and Regulations (173-186)

9 Market Obstacles and Creating Incentives (187-200)

Appendix A: Acknowledgments (201-206)

Appendix B: Organization and Mission Statements of NIDA's Medications Development Division and Its Branches (207-210)

Appendix C: Diagnostic Criteria for Psychoactive Substance Dependence (211-214)

Appendix D: Survey of Pharmaceutical Companies (215-226)

Appendix E: Model Federal Programs in Pharmaceutical R&D (227-237)

Appendix F: Workshop Agenda and Participants (238-241)

Appendix G: Health Care Reform Legislation (242-247)

Appendix H: Acronyms (248-250)